Mezzion Pharma Co.Ltd (140410) — Cash Flow Reinvestment Rate

Latest as of September 2023: 2.33x

Mezzion Pharma Co.Ltd (140410) has a Cash Flow Reinvestment Rate of 2.33x as of September 2023, reinvesting ₩11.01 Billion (capex ₩5.46 Billion plus investments ₩-5.55 Billion) from operating cash flow of ₩4.73 Billion. See Mezzion Pharma Co.Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.33x
(Capex + Investments) / Operating CF

Total Reinvested

₩11.01 Billion
Capex + Investments

Operating Cash Flow

₩4.73 Billion
KRW

Capital Expenditures

₩5.46 Billion
KRW

Mezzion Pharma Co.Ltd Cash Flow Reinvestment Rate (2012–2015)

Historical reinvestment intensity for Mezzion Pharma Co.Ltd across 2 annual periods. For the full cash flow conversion analysis, see 140410 cash flow metrics.

Annual Cash Flow Reinvestment Rate for Mezzion Pharma Co.Ltd (2012–2015)

Year-by-year capital reinvestment analysis for Mezzion Pharma Co.Ltd. See 140410 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2015 0.55x ₩983.20 Million ₩1.77 Billion ₩564.10 Million ▲ +77.0%
2012 0.31x ₩983.20 Million ₩3.14 Billion ₩564.10 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow